CLARIANE SE (CLARI.PA) Stock Fundamental Analysis
EPA:CLARI - Euronext Paris - Matif - FR0010386334 - Common Stock - Currency: EUR
Overall CLARI gets a fundamental rating of 2 out of 10. We evaluated CLARI against 25 industry peers in the Health Care Providers & Services industry. CLARI may be in some trouble as it scores bad on both profitability and health. CLARI is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CLARI has reported negative net income.
CLARI had a positive operating cash flow in the past year.
In multiple years CLARI reported negative net income over the last 5 years.
Each year in the past 5 years CLARI had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -0.39%, CLARI is doing worse than 80.00% of the companies in the same industry.
With a Return On Equity value of -1.49%, CLARI is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 1.86%, CLARI is doing worse than 76.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CLARI is below the industry average of 5.74%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.39% | ||
| ROE | -1.49% | ||
| ROIC | 1.86% |
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
1.3 Margins
The Operating Margin of CLARI (5.44%) is comparable to the rest of the industry.
CLARI's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 91.68%, CLARI belongs to the best of the industry, outperforming 96.00% of the companies in the same industry.
In the last couple of years the Gross Margin of CLARI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.44% | ||
| PM (TTM) | N/A | ||
| GM | 91.68% |
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CLARI is destroying value.
CLARI has more shares outstanding than it did 1 year ago.
CLARI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CLARI has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.63, we must say that CLARI is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.63, CLARI is doing worse than 68.00% of the companies in the same industry.
CLARI has a debt to FCF ratio of 13.44. This is a negative value and a sign of low solvency as CLARI would need 13.44 years to pay back of all of its debts.
CLARI has a Debt to FCF ratio of 13.44. This is in the lower half of the industry: CLARI underperforms 68.00% of its industry peers.
CLARI has a Debt/Equity ratio of 1.78. This is a high value indicating a heavy dependency on external financing.
CLARI's Debt to Equity ratio of 1.78 is on the low side compared to the rest of the industry. CLARI is outperformed by 68.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.78 | ||
| Debt/FCF | 13.44 | ||
| Altman-Z | 0.63 |
ROIC/WACC0.48
WACC3.89%
2.3 Liquidity
A Current Ratio of 0.56 indicates that CLARI may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.56, CLARI is doing worse than 84.00% of the companies in the same industry.
A Quick Ratio of 0.56 indicates that CLARI may have some problems paying its short term obligations.
With a Quick ratio value of 0.56, CLARI is not doing good in the industry: 76.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.56 | ||
| Quick Ratio | 0.56 |
3. Growth
3.1 Past
CLARI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.18%, which is quite impressive.
The Revenue has been growing slightly by 5.73% in the past year.
Measured over the past years, CLARI shows a small growth in Revenue. The Revenue has been growing by 7.89% on average per year.
EPS 1Y (TTM)22.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.24%
Revenue 1Y (TTM)5.73%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%4.4%
3.2 Future
CLARI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 64.62% yearly.
The Revenue is expected to grow by 3.79% on average over the next years.
EPS Next Y157.21%
EPS Next 2Y90.37%
EPS Next 3Y64.62%
EPS Next 5YN/A
Revenue Next Year2.46%
Revenue Next 2Y3.51%
Revenue Next 3Y3.79%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
CLARI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 31.21, CLARI can be considered very expensive at the moment.
CLARI's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CLARI is more expensive than 72.00% of the companies in the same industry.
CLARI's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 36.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 31.21 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as CLARI.
Based on the Price/Free Cash Flow ratio, CLARI is valued cheaply inside the industry as 92.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.63 | ||
| EV/EBITDA | 9.07 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CLARI's earnings are expected to grow with 64.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y90.37%
EPS Next 3Y64.62%
5. Dividend
5.1 Amount
CLARI has a Yearly Dividend Yield of 10.64%, which is a nice return.
CLARI's Dividend Yield is rather good when compared to the industry average which is at 2.85. CLARI pays more dividend than 100.00% of the companies in the same industry.
CLARI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.64% |
5.2 History
The dividend of CLARI decreases each year by -5.96%.
Dividend Growth(5Y)-5.96%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of CLARI are negative and hence is the payout ratio. CLARI will probably not be able to sustain this dividend level.
DP-92.12%
EPS Next 2Y90.37%
EPS Next 3Y64.62%
EPA:CLARI (8/6/2025, 7:00:00 PM)
4.372
+0.01 (+0.23%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners42.42%
Inst Owner ChangeN/A
Ins Owners5.64%
Ins Owner ChangeN/A
Market Cap1.56B
Analysts75.38
Price Target4.58 (4.76%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.64% |
Yearly Dividend0.21
Dividend Growth(5Y)-5.96%
DP-92.12%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)36.94%
PT rev (3m)63.93%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.39%
Revenue NY rev (3m)-2.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 31.21 | ||
| P/S | 0.3 | ||
| P/FCF | 2.63 | ||
| P/OCF | 1.73 | ||
| P/B | 0.42 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.07 |
EPS(TTM)-0.47
EYN/A
EPS(NY)0.14
Fwd EY3.2%
FCF(TTM)1.66
FCFY37.96%
OCF(TTM)2.52
OCFY57.71%
SpS14.81
BVpS10.35
TBVpS-5.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.39% | ||
| ROE | -1.49% | ||
| ROCE | 2.53% | ||
| ROIC | 1.86% | ||
| ROICexc | 1.95% | ||
| ROICexgc | 4.01% | ||
| OM | 5.44% | ||
| PM (TTM) | N/A | ||
| GM | 91.68% | ||
| FCFM | 11.21% |
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
ROICexc(3y)2.07%
ROICexc(5y)2.22%
ROICexgc(3y)4.16%
ROICexgc(5y)4.53%
ROCE(3y)2.66%
ROCE(5y)2.78%
ROICexcg growth 3Y-9.02%
ROICexcg growth 5Y-8.45%
ROICexc growth 3Y-9.61%
ROICexc growth 5Y-8.51%
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
F-Score5
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.78 | ||
| Debt/FCF | 13.44 | ||
| Debt/EBITDA | 6.65 | ||
| Cap/Depr | 43.77% | ||
| Cap/Sales | 5.83% | ||
| Interest Coverage | 0.96 | ||
| Cash Conversion | 90.82% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.56 | ||
| Quick Ratio | 0.56 | ||
| Altman-Z | 0.63 |
F-Score5
WACC3.89%
ROIC/WACC0.48
Cap/Depr(3y)69.7%
Cap/Depr(5y)78.91%
Cap/Sales(3y)9.85%
Cap/Sales(5y)11.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.24%
EPS Next Y157.21%
EPS Next 2Y90.37%
EPS Next 3Y64.62%
EPS Next 5YN/A
Revenue 1Y (TTM)5.73%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%4.4%
Revenue Next Year2.46%
Revenue Next 2Y3.51%
Revenue Next 3Y3.79%
Revenue Next 5YN/A
EBIT growth 1Y-8.92%
EBIT growth 3Y-9.18%
EBIT growth 5Y-4.33%
EBIT Next Year308.46%
EBIT Next 3Y69.88%
EBIT Next 5YN/A
FCF growth 1Y85%
FCF growth 3Y23.92%
FCF growth 5Y6.15%
OCF growth 1Y11.93%
OCF growth 3Y2.33%
OCF growth 5Y3.29%